Repositori URV

Identificador: imarina:9249027

Handle: https://hdl.handle.net/20.500.11797/imarina9249027

Autors:
Grau-Bove, CarmeGonzalez-Quilen, CarlosCantini, GiuliaNardini, PatriziaEspina, BeatrizBani, DanieleTerra, XimenaBlay, MTeresaRodriguez-Gallego, EstherLuconi, MichaelaArdevol, AnnaPinent, Montserrat

Resum:
GLP1 produced in the upper part of the gut is released after food intake and acts by activat-ing insulin secretion, but the role of GLP1 in the colon, where it is predominantly produced, remains unknown. Here we characterized the apical versus basolateral secretion of GLP1 and PYY and the paracrine mechanisms of action of these enterohormones in the human colon. We stimulated human colon tissue in different ex vivo models with meat peptone and we used immunofluorescence to study the presence of canonical and non-canonical receptors of GLP1. We found that PYY and GLP1 are secreted mainly at the gut lumen in unstimulated and stimulated conditions. We detected DPP4 activity and found that GLP1R and GCGR are widely expressed in the human colon epithelium. Unlike GLP1R, GCGR is not expressed in the lamina propria, but it is located in the crypts of Lieberkühn. We detected GLP1R expression in human colon cell culture models. We show that the apical secretion of PYY and GLP1 occurs in humans, and we provide evidence that GLP1 has a potential direct paracrine function through the expression of its receptors in the colon epithelium, opening new therapeutic perspectives in the use of enterohormones analogues in metabolic pathologies.